| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |